• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及伊斯梅利亚重症监护病房患者中氨基糖苷类耐药性及氨基糖苷类修饰酶的流行情况

Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Among Intensive Care Unit Patients, Ismailia, Egypt.

作者信息

Kishk Rania, Soliman Nourhan, Nemr Nader, Eldesouki Raghda, Mahrous Nageh, Gobouri Adil, Azab Ehab, Anani Maha

机构信息

Microbiology and Immunology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

出版信息

Infect Drug Resist. 2021 Jan 19;14:143-150. doi: 10.2147/IDR.S290584. eCollection 2021.

DOI:10.2147/IDR.S290584
PMID:33519215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7838519/
Abstract

BACKGROUND

is an opportunistic pathogen that rapidly develops antibiotic resistance against commonly prescribed antimicrobial agents in hospitalized patients worldwide. Aminoglycosides are commonly used in the treatment of health care-associated infections (HAIs). Aminoglycosides resistance mechanisms are varied and commonly involve production of aminoglycoside-modifying enzymes (AME) and efflux systems.

AIM

This study aimed to provide an insight into the frequency of genes encoding AME in strains isolated from different clinical specimens in intensive care units (ICU).

METHODOLOGY

A total of 52 multidrug-resistant (MDR) strains were isolated from ICU, Suez Canal University Hospitals. Species identification and antibiotics susceptibility testing were done by the automated system VITEK 2. The genes encoding AME were detected by PCR.

RESULTS

Aminoglycosides resistance (amikacin, gentamicin and tobramycin) was observed in 35 isolates (67.3%). We found that aacC1 gene was the predominant AME resistance gene among isolates, detected in 14 isolates (40%), aphA6 in 11 isolates (31.4%) and addA1 in 5 isolates (14.2%). We found 5 isolates containing 2 AME genes, 3 of them with aacC1 and aphA6 and the remaining 2 with both aacC1 and aadA1 genes. Nearly, 5 isolates (14.2%) were negative for all AME resistance genes.

CONCLUSION

Our study indicated that AME encoding genes are predominant in strains in our region which stressed on the importance of preventive measures to control spreading of resistance genes.

摘要

背景

是一种机会致病菌,在全球范围内的住院患者中,它会迅速对常用的抗菌药物产生耐药性。氨基糖苷类药物常用于治疗医疗保健相关感染(HAIs)。氨基糖苷类耐药机制多种多样,通常涉及氨基糖苷类修饰酶(AME)的产生和外排系统。

目的

本研究旨在深入了解重症监护病房(ICU)中从不同临床标本分离出的菌株中编码AME的基因频率。

方法

从苏伊士运河大学医院的ICU共分离出52株多重耐药(MDR)菌株。通过VITEK 2自动化系统进行菌种鉴定和抗生素敏感性测试。通过PCR检测编码AME的基因。

结果

在35株分离株(67.3%)中观察到对氨基糖苷类药物(阿米卡星、庆大霉素和妥布霉素)耐药。我们发现aacC1基因是分离株中主要的AME耐药基因,在14株(40%)中检测到,aphA6在11株(31.4%)中检测到,addA1在5株(14.2%)中检测到。我们发现5株分离株含有2个AME基因,其中3株同时含有aacC1和aphA6,其余2株同时含有aacC1和aadA1基因。近5株(14.2%)对所有AME耐药基因均为阴性。

结论

我们的研究表明,编码AME的基因在我们地区的菌株中占主导地位,这强调了采取预防措施控制耐药基因传播的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/0a279ae96fc1/IDR-14-143-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/98206bba087c/IDR-14-143-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/beac865152e5/IDR-14-143-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/0a279ae96fc1/IDR-14-143-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/98206bba087c/IDR-14-143-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/beac865152e5/IDR-14-143-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ce/7838519/0a279ae96fc1/IDR-14-143-g0003.jpg

相似文献

1
Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Among Intensive Care Unit Patients, Ismailia, Egypt.埃及伊斯梅利亚重症监护病房患者中氨基糖苷类耐药性及氨基糖苷类修饰酶的流行情况
Infect Drug Resist. 2021 Jan 19;14:143-150. doi: 10.2147/IDR.S290584. eCollection 2021.
2
Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of from Ahvaz, south-west Iran.评估伊朗西南部阿瓦士临床分离株中碳青霉烯类和氨基糖苷类耐药基因的频率。
New Microbes New Infect. 2020 Oct 10;38:100779. doi: 10.1016/j.nmni.2020.100779. eCollection 2020 Nov.
3
Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates.鲍曼不动杆菌分离株中氨基糖苷类耐药基因的流行情况。
Jundishapur J Microbiol. 2014 Oct;7(10):e11924. doi: 10.5812/jjm.11924. Epub 2014 Oct 1.
4
Prevalence of Genes Encoding Aminoglycoside-Modifying Enzymes and armA among Acinetobacter baumannii Clinical Isolates in Alexandria, Egypt.埃及亚历山大市鲍曼不动杆菌临床分离株中编码氨基糖苷类修饰酶和armA基因的流行情况
Infect Disord Drug Targets. 2021;21(8):e300821191828. doi: 10.2174/1871526521666210225113041.
5
Aminoglycoside Resistance Genes in Acinetobacter baumannii Clinical Isolates.鲍曼不动杆菌临床分离株中的氨基糖苷类耐药基因
Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190103.
6
Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons.从德黑兰医院医院感染中分离出的多重耐药鲍曼不动杆菌基因型中氨基糖苷类修饰酶基因的多样性及其与1类整合子的关联
Acta Microbiol Immunol Hung. 2011 Dec;58(4):359-70. doi: 10.1556/AMicr.58.2011.4.11.
7
[Aminoglycoside resistance of Acinetobacter baumannii hospital strains in the Czech Republic].[捷克共和国医院鲍曼不动杆菌菌株的氨基糖苷类耐药性]
Klin Mikrobiol Infekc Lek. 2004 Oct;10(5):223-8.
8
Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex.鲍曼不动杆菌-醋酸钙不动杆菌复合体中的氨基糖苷类耐药性和药敏试验误差。
J Clin Microbiol. 2010 Apr;48(4):1132-8. doi: 10.1128/JCM.02006-09. Epub 2010 Jan 27.
9
Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. With emergence of multidrug-resistant strains.不动杆菌属中氨基糖苷类耐药的分子流行病学。随着多重耐药菌株的出现。
Iran J Public Health. 2010;39(2):63-8. Epub 2010 Jun 30.
10
Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides.氨基糖苷类修饰酶和 16S rRNA 甲基化酶(ArmA)在鲍曼不动杆菌临床分离株对氨基糖苷类药物耐药中的作用。
Rev Soc Bras Med Trop. 2021 Jan 29;54:e05992020. doi: 10.1590/0037-8682-0599-2020. eCollection 2021.

引用本文的文献

1
Efficacy of Endolysin LysAB1245 Combined with Colistin as Adjunctive Therapy Against Colistin-Resistant Gram-Negative Bacteria.内溶素LysAB1245联合黏菌素作为辅助疗法对抗耐黏菌素革兰氏阴性菌的疗效
Antibiotics (Basel). 2025 May 23;14(6):538. doi: 10.3390/antibiotics14060538.
2
Signaling in : Quorum sensing and nucleotide second messengers.信号传入:群体感应与核苷酸第二信使
Comput Struct Biotechnol J. 2025 May 22;27:2168-2175. doi: 10.1016/j.csbj.2025.05.032. eCollection 2025.
3
RegRNA 3.0: expanding regulatory RNA analysis with new features for motif, interaction, and annotation.

本文引用的文献

1
Characterization of aminoglycoside resistance mechanisms in Acinetobacter Baumannii isolates from burn wound colonization.鲍曼不动杆菌烧伤创面定植菌株中氨基糖苷类耐药机制的特征分析
Ann Burns Fire Disasters. 2019 Jun 30;32(2):115-121.
2
Diversity of aminoglycoside modifying enzymes and 16S rRNA methylases in Acinetobacter baumannii and Acinetobacter nosocomialis species in Iran; wide distribution of aadA1 and armA.伊朗鲍曼不动杆菌和琼氏不动杆菌中氨基糖苷类修饰酶和 16S rRNA 甲基酶的多样性;aadA1 和 armA 的广泛分布。
Infect Genet Evol. 2018 Dec;66:195-199. doi: 10.1016/j.meegid.2018.09.028. Epub 2018 Oct 4.
3
RegRNA 3.0:通过用于基序、相互作用和注释的新功能扩展调控RNA分析
Nucleic Acids Res. 2025 Jul 7;53(W1):W485-W495. doi: 10.1093/nar/gkaf405.
4
Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against .环肽MV6,一种针对……的氨基糖苷类增效剂
Antibiotics (Basel). 2024 Dec 1;13(12):1147. doi: 10.3390/antibiotics13121147.
5
Deciphering the structure of a multi-drug resistant Acinetobacter baumannii short-chain dehydrogenase reductase.解析多药耐药鲍曼不动杆菌短链脱氢酶还原酶的结构。
PLoS One. 2024 Feb 23;19(2):e0297751. doi: 10.1371/journal.pone.0297751. eCollection 2024.
6
Characterization of a novel bacteriophage endolysin (LysAB1245) with extended lytic activity against distinct capsular types associated with Acinetobacter baumannii resistance.鉴定一种新型噬菌体溶菌酶(LysAB1245),该酶对与鲍曼不动杆菌耐药性相关的不同荚膜型具有广泛的溶菌活性。
PLoS One. 2024 Jan 2;19(1):e0296453. doi: 10.1371/journal.pone.0296453. eCollection 2024.
7
Comparison of loop-mediated isothermal amplification, multiplex PCR, and REP- PCR techniques for identification of carbapenem-resistant clinical isolates.环介导等温扩增、多重PCR和REP-PCR技术用于鉴定耐碳青霉烯临床分离株的比较
Iran J Microbiol. 2023 Oct;15(5):654-664. doi: 10.18502/ijm.v15i5.13871.
8
Molecular characterization of multidrug resistant clinical isolates from Alexandria, Egypt.埃及亚历山大的多重耐药临床分离株的分子特征。
Front Cell Infect Microbiol. 2023 Jul 20;13:1208046. doi: 10.3389/fcimb.2023.1208046. eCollection 2023.
9
Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced .探索广泛耐药和泛耐药(XDR和PDR)全基因组测序中的协同组合
Microorganisms. 2023 May 26;11(6):1409. doi: 10.3390/microorganisms11061409.
10
Mobile genetic elements carrying aminoglycoside resistance genes in isolates belonging to global clone 2.属于全球克隆2的分离株中携带氨基糖苷类耐药基因的移动遗传元件。
Front Microbiol. 2023 May 5;14:1172861. doi: 10.3389/fmicb.2023.1172861. eCollection 2023.
High-level aminoglycoside resistance in recovered from Intensive Care Unit patients in Northeastern India.
从印度东北部重症监护病房患者中分离出的高水平氨基糖苷类耐药性。 (原句表述不太完整和准确,翻译出来的中文也稍显生硬,推测完整准确的原文可能是“High-level aminoglycoside resistance bacteria recovered from Intensive Care Unit patients in Northeastern India.” 这样翻译会更通顺合理:从印度东北部重症监护病房患者中分离出的高水平氨基糖苷类耐药菌 )
Indian J Med Microbiol. 2018 Jan-Mar;36(1):43-48. doi: 10.4103/ijmm.IJMM_17_225.
4
LPSN - List of Prokaryotic names with Standing in Nomenclature (bacterio.net), 20 years on.LPSN - 《细菌命名法中有效发表的原核生物名称列表》(bacterio.net),二十年回顾。
Int J Syst Evol Microbiol. 2018 Jun;68(6):1825-1829. doi: 10.1099/ijsem.0.002786. Epub 2018 May 4.
5
A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.多中心研究多重耐药鲍曼不动杆菌感染的危险因素。
BMC Infect Dis. 2018 Jan 5;18(1):11. doi: 10.1186/s12879-017-2932-5.
6
Biology of : Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.生物学:发病机制、抗生素耐药机制及潜在治疗方案
Front Cell Infect Microbiol. 2017 Mar 13;7:55. doi: 10.3389/fcimb.2017.00055. eCollection 2017.
7
Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii.全面研究以探究各种氨基糖苷类耐药机制在鲍曼不动杆菌临床分离株中的作用。
J Infect Chemother. 2017 Feb;23(2):74-79. doi: 10.1016/j.jiac.2016.09.012. Epub 2016 Nov 23.
8
Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.新出现的耐药性、新的抗菌药物……但没有检测!当前美国监管格局下抗菌药物敏感性检测面临的挑战。
Clin Infect Dis. 2016 Jul 1;63(1):83-8. doi: 10.1093/cid/ciw201. Epub 2016 Mar 29.
9
Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China.中国北京鲍曼不动杆菌高水平氨基糖苷类耐药的遗传基础
Acta Pharm Sin B. 2014 Aug;4(4):295-300. doi: 10.1016/j.apsb.2014.06.004. Epub 2014 Jul 15.
10
Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran.伊朗东北部鲍曼不动杆菌临床分离株的遗传多样性有限及广泛的抗菌药物耐药性
J Med Microbiol. 2015 Jul;64(7):767-773. doi: 10.1099/jmm.0.000090. Epub 2015 May 19.